| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4249070 | Revista Española de Medicina Nuclear | 2008 | 7 Pages |
Abstract
FDG-PET has high sensitivity and clinical impact in patients with suspicion of recurrent ovarian cancer. Better results were obtained in patients with increased tumour markers and negative MIT.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
J.I. Cuenca Cuenca, I. Borrego Dorado, R. Vázquez Albertino, P. Gómez Camarero, S. Sanz Viedma, R. Fernández López,